← Leaderboards
Ray Stokes Peebles
Vanderbilt University Medical Center
$23,791,995
Attributed
$24,912,585
Total exposure
26
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.2M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$56,810,689 · 25
VA$0 · 2
By mechanism
U19$39,642,221 · 13
R01$14,790,904 · 8
T32$1,249,875 · 1
R21$906,235 · 2
K08$221,454 · 1
I01$0 · 2
Top collaborators
- Kevin D Niswender5 shared
- Tina V Hartert2 shared
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaCytokineLungImmune ResponseProductionInterleukin-13AllergensResponseHypersensitivitySignal TransductionIn VivoIn VitroAllergic Airway InflammationViralCellsInfantChildhoodEpithelial CellsPublishingMediatingMouse ModelUnited StatesReceptorClinically Significant
Grant awards (118)
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,526,298
U19 · FY2025 · AI
Interdisciplinary Training Program in Lung Research$425,333
T32 · FY2025 · HL · contact PI
RSV-induced type 2 immune responses are inhibited by dietary citrulline supplementation during gestation and early life$377,807
U19 · FY2025 · AI · contact PI
Administrative Core$71,576
U19 · FY2025 · AI · contact PI
PGI2 regulation of CD4+ Th2 metabolism in allergic airway inflammation$0
I01 · FY2025 · VA · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,526,769
U19 · FY2024 · AI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,094,138
U19 · FY2024 · AI · contact PI
RSV-induced type 2 immune responses are inhibited by dietary citrulline supplementation during gestation and early life$482,334
U19 · FY2024 · AI · contact PI
Interdisciplinary Training Program in Lung Research$413,798
T32 · FY2024 · HL · contact PI
Administrative Core$72,979
U19 · FY2024 · AI · contact PI
PGI2 regulation of CD4+ Th2 metabolism in allergic airway inflammation$0
I01 · FY2024 · VA · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,527,291
U19 · FY2023 · AI · contact PI
PGI2 augments Treg function$535,602
R01 · FY2023 · AI · contact PI
RSV-induced type 2 immune responses are inhibited by dietary citrulline supplementation during gestation and early life$456,805
U19 · FY2023 · AI · contact PI
Interdisciplinary Training Program in Lung Research$410,744
T32 · FY2023 · HL · contact PI
Administrative Core$68,503
U19 · FY2023 · AI · contact PI
PGI2 regulation of CD4+ Th2 metabolism in allergic airway inflammation$0
I01 · FY2023 · VA · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,493,162
U19 · FY2022 · AI · contact PI
PGI2 augments Treg function$535,602
R01 · FY2022 · AI · contact PI
RSV-induced type 2 immune responses are inhibited by dietary citrulline supplementation during gestation and early life$534,172
U19 · FY2022 · AI · contact PI
Administrative Core$15,237
U19 · FY2022 · AI · contact PI
PGI2 inhibition of pulmonary innate allergic immune responses$0
I01 · FY2022 · VA · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,517,100
U19 · FY2021 · AI · contact PI
RSV-induced type 2 immune responses are inhibited by dietary citrulline supplementation during gestation and early life$550,563
U19 · FY2021 · AI · contact PI
PGI2 augments Treg function$535,602
R01 · FY2021 · AI · contact PI
GLP-1R signaling in allergic inflammation$397,523
R01 · FY2021 · AI · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$164,815
U19 · FY2021 · AI · contact PI
Administrative Core$63,730
U19 · FY2021 · AI · contact PI
PGI2 inhibition of pulmonary innate allergic immune responses$0
I01 · FY2021 · VA · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,550,210
U19 · FY2020 · AI · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,505,841
U19 · FY2020 · AI · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,343,390
U19 · FY2020 · AI · contact PI
PGI2 augments Treg function$535,602
R01 · FY2020 · AI · contact PI
2stop-A4G genotype in RSV-induced bronchiolitis and asthma$420,190
U19 · FY2020 · AI · contact PI
GLP-1R signaling in allergic inflammation$397,523
R01 · FY2020 · AI · contact PI
Host genetics of allergen-induced lung TSLP expression and ILC2 function$212,500
R21 · FY2020 · AI · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$102,000
U19 · FY2020 · AI · contact PI
Infrastructure and Opportunity Fund Management Core$92,899
U19 · FY2020 · AI · contact PI
PGI2 inhibition of pulmonary innate allergic immune responses$0
I01 · FY2020 · VA · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,380,535
U19 · FY2019 · AI · contact PI
PGI2 augments Treg function$535,602
R01 · FY2019 · AI · contact PI
GLP-1R signaling in allergic inflammation$483,104
R01 · FY2019 · AI · contact PI
2stop-A4G genotype in RSV-induced bronchiolitis and asthma$431,811
U19 · FY2019 · AI · contact PI
Host genetics of allergen-induced lung TSLP expression and ILC2 function$255,000
R21 · FY2019 · AI · contact PI
Infrastructure and Opportunity Fund Management Core$95,471
U19 · FY2019 · AI · contact PI
PGI2 inhibition of pulmonary innate allergic immune responses$0
I01 · FY2019 · VA · contact PI
PGI2 inhibition of pulmonary innate allergic immune responses$0
I01 · FY2019 · VA · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,485,056
U19 · FY2018 · AI · contact PI
GLP-1R signaling in allergic inflammation$568,031
R01 · FY2018 · AI · contact PI
PGI2 regulation of TSLP-mediated allergic inflammation in the lung$395,000
R01 · FY2018 · AI · contact PI
2stop-A4G genotype in RSV-induced bronchiolitis and asthma$347,889
U19 · FY2018 · AI · contact PI
Infrastructure and Opportunity Fund Management Core$78,089
U19 · FY2018 · AI · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,407,057
U19 · FY2017 · AI · contact PI
2stop-A4G genotype in RSV-induced bronchiolitis and asthma$400,287
U19 · FY2017 · AI · contact PI
PGI2 regulation of TSLP-mediated allergic inflammation in the lung$395,000
R01 · FY2017 · AI · contact PI
GLP-1R signaling in allergic inflammation$395,000
R01 · FY2017 · AI · contact PI
Infrastructure and Opportunity Fund Management Core$79,032
U19 · FY2017 · AI · contact PI
PGI2 inhibition of pulmonary innate allergic immune responses$0
I01 · FY2017 · VA · contact PI
Viral and Host Determinants of Infant and Childhood Allergy and Asthma$1,827,104
U19 · FY2016 · AI · contact PI
2stop-A4G genotype in RSV-induced bronchiolitis and asthma$406,218
U19 · FY2016 · AI · contact PI
PGI2 regulation of TSLP-mediated allergic inflammation in the lung$356,764
R01 · FY2016 · AI · contact PI
Administrative Core$69,312
U19 · FY2016 · AI · contact PI
PGI2 regulation of TSLP-mediated allergic inflammation in the lung$37,994
R01 · FY2016 · AI · contact PI
Infrastructure and Opportunity Fund Management Core$1
U19 · FY2016 · AI · contact PI
PGI2 inhibition of pulmonary innate allergic immune responses$0
I01 · FY2016 · VA · contact PI
Host and Viral Determinants of Infant and Childhood Allergy and Asthma$1,676,019
U19 · FY2015 · AI · contact PI
The role of PGI2 in RSV-induced airway dysfunction and illness$404,508
U19 · FY2015 · AI · contact PI
PGI2 regulation of TSLP-mediated allergic inflammation in the lung$392,500
R01 · FY2015 · AI · contact PI
Host and Viral Determinants of Infant and Childhood Allergy and Asthma$226,280
U19 · FY2015 · AI · contact PI
Administrative Core$134,517
U19 · FY2015 · AI · contact PI
The role of PGI2 in RSV-induced airway dysfunction and illness$46,780
U19 · FY2015 · AI · contact PI
Administrative Core$11,090
U19 · FY2015 · AI · contact PI
PGI2 inhibition of pulmonary innate allergic immune responses$0
I01 · FY2015 · VA · contact PI
Host and Viral Determinants of Infant and Childhood Allergy and Asthma$2,656,082
U19 · FY2014 · AI · contact PI
PGI2 regulation of TSLP-mediated allergic inflammation in the lung$391,875
R01 · FY2014 · AI · contact PI
The role of PGI2 in RSV-induced airway dysfunction and illness$386,171
U19 · FY2014 · AI · contact PI
Administrative Core$200,795
U19 · FY2014 · AI · contact PI
PGI2 inhibition of pulmonary innate allergic immune responses$0
I01 · FY2014 · VA · contact PI
Host and Viral Determinants of Infant and Childhood Allergy and Asthma$2,705,916
U19 · FY2013 · AI · contact PI
The Role of PGI2 in Allergic Inflammation$361,677
R01 · FY2013 · HL · contact PI
The role of PGI2 in RSV-induced airway dysfunction and illness$288,695
U19 · FY2013 · AI · contact PI
Administrative Core$159,078
U19 · FY2013 · AI · contact PI
The role of cyclooxygenase in the adaptive immune response and tolerance$0
I01 · FY2013 · VA · contact PI
Host and Viral Determinants of Infant and Childhood Allergy and Asthma$3,332,536
U19 · FY2012 · AI · contact PI
The Role of PGI2 in Allergic Inflammation$379,913
R01 · FY2012 · HL · contact PI
The role of PGI2 in RSV-induced airway dysfunction and illness$295,510
U19 · FY2012 · AI · contact PI
The Role of Il-13 in Regulating Th17 Cytokine Production$196,422
R21 · FY2012 · HL · contact PI
Administrative Core$153,654
U19 · FY2012 · AI · contact PI
The role of cyclooxygenase in the adaptive immune response and tolerance$0
I01 · FY2012 · VA · contact PI
Host and Viral Determinants of Infant and Childhood Allergy and Asthma$1,850,505
U19 · FY2011 · AI · contact PI
The Role of PGI2 in Allergic Inflammation$383,750
R01 · FY2011 · HL · contact PI
The Role of IL-17 in RSV-induced Mucus and Airway Responsiveness$365,231
R01 · FY2011 · AI · contact PI
The role of PGI2 in RSV-induced airway dysfunction and illness$254,482
U19 · FY2011 · AI · contact PI
The Role of Il-13 in Regulating Th17 Cytokine Production$242,313
R21 · FY2011 · HL · contact PI
Administrative Core$216,889
U19 · FY2011 · AI · contact PI
Infrastructure and Opportunity Fund Management$77,043
U19 · FY2011 · AI · contact PI
The role of cyclooxygenase in the adaptive immune response and tolerance$0
I01 · FY2011 · VA · contact PI
The Role of PGI2 in Allergic Inflammation$383,750
R01 · FY2010 · HL · contact PI
The Role of IL-17 in RSV-induced Mucus and Airway Responsiveness$369,028
R01 · FY2010 · AI · contact PI
The Role of PGI2 in Allergic Inflammation$383,750
R01 · FY2009 · HL · contact PI
The Role of IL-17 in RSV-induced Mucus and Airway Responsiveness$372,864
R01 · FY2009 · AI · contact PI
The role of cyclooxygenase in the adaptive immune response and tolerance$0
I01 · FY2009 · VA · contact PI
The Role of IL-17 in RSV-induced Mucus and Airway Responsiveness$372,969
R01 · FY2008 · AI · contact PI
The Role of IL-17 in RSV-induced Mucus and Airway Responsiveness$393,671
R01 · FY2007 · AI · contact PI
PGE2 Regulation of Allergic Inflammation in the Lung$357,938
R01 · FY2007 · HL · contact PI
Prostacyclin (PG12) Regulation of Respiratory Syncytial Virus (RS)induced Illness$322,145
R01 · FY2007 · AI · contact PI
PGE2 Regulation of Allergic Inflammation in the Lung$368,629
R01 · FY2006 · HL · contact PI
Prostacyclin (PG12) Regulation of RSV-induced Illness$331,767
R01 · FY2006 · AI · contact PI
PGE2 Regulation of Allergic Inflammation in the Lung$377,500
R01 · FY2005 · HL
Prostacyclin (PG12) Regulation of RSV-induced Illness$339,750
R01 · FY2005 · AI
PGE2 Regulation of Allergic Inflammation in the Lung$377,500
R01 · FY2004 · HL
Prostacyclin (PG12) Regulation of RSV-induced Illness$339,750
R01 · FY2004 · AI
PGE2 Regulation of Allergic Inflammation in the Lung$377,500
R01 · FY2003 · HL
Prostacyclin (PGI2) Regulation of RSV-induced Illness$339,750
R01 · FY2003 · AI
RESPIRATORY SYNCYTIAL VIRUS ON ALLERGIC AIRWAY DISEASE$305,192
R01 · FY2003 · AI
RESPIRATORY SYNCYTIAL VIRUS ON ALLERGIC AIRWAY DISEASE$298,556
R01 · FY2002 · AI
AIRWAY REACTIVITY INDUCED BY VIRUS (RSV) AND ALLERGY$110,727
K08 · FY2001 · HL
AIRWAY REACTIVITY INDUCED BY VIRUS (RSV) AND ALLERGY$110,727
K08 · FY2000 · HL